PHP
TMO icon

Parkman Healthcare Partners’s Thermo Fisher Scientific TMO Stock Holding History

Parkman Healthcare Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,572
Closed -$9.05M – 109
2024
Q1 		$9.05M Buy
15,572
+5,572
+56% +$3.13M 1.11% 34
2023
Q4 		$5.31M Sell
10,000
-5,332
-35% -$2.58M 0.75% 42
2023
Q3 		$7.76M Buy
+15,332
New +$8.17M 1.42% 22
2022
Q4 		– Sell
-7,500
Closed -$3.8M – 93
2022
Q3 		$3.8M Buy
+7,500
New +$4.2M 1.08% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parkman Healthcare Partners's TMO Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 15,572 shares — an estimated $9.05M sold.

Parkman Healthcare Partners first reported a position in TMO in Q3 2022 and held it in 4 quarters. The position peaked at $9.05M in Q1 2024. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Parkman Healthcare Partners reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 15,572 Thermo Fisher Scientific shares in Q2 2024, an estimated $9.05M.
  • Parkman Healthcare Partners first reported a position in Thermo Fisher Scientific in Q3 2022 and held it in 4 quarters.
  • Parkman Healthcare Partners's Thermo Fisher Scientific position peaked at $9.05M in Q1 2024.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.